| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 11.895 | 60.926 | 40.146 | 59.865 | 59.629 | 97.688 | 233.922 |
| Total Income - EUR | - | - | - | 11.895 | 60.926 | 40.146 | 59.865 | 59.629 | 97.688 | 237.541 |
| Total Expenses - EUR | - | - | - | 8.192 | 37.458 | 26.381 | 44.063 | 38.608 | 62.024 | 148.416 |
| Gross Profit/Loss - EUR | - | - | - | 3.703 | 23.468 | 13.765 | 15.801 | 21.021 | 35.665 | 89.125 |
| Net Profit/Loss - EUR | - | - | - | 3.584 | 22.859 | 13.531 | 15.316 | 20.424 | 34.688 | 83.048 |
| Employees | - | - | - | 1 | 1 | 2 | 3 | 1 | 3 | 5 |
Check the financial reports for the company - Doxicomdes S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 324 | 318 | 312 | 305 | 306 | 305 | 1.520 |
| Current Assets | - | - | - | 5.395 | 27.933 | 13.835 | 21.999 | 34.494 | 44.748 | 146.476 |
| Inventories | - | - | - | 5.212 | 10.524 | 12.143 | 11.232 | 15.579 | 16.613 | 35.925 |
| Receivables | - | - | - | 0 | 10.537 | 932 | 10.380 | 18.250 | 22.559 | 80.850 |
| Cash | - | - | - | 183 | 6.872 | 759 | 388 | 666 | 5.576 | 29.702 |
| Shareholders Funds | - | - | - | 3.627 | 22.909 | 13.580 | 15.364 | 20.473 | 34.736 | 83.097 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 2.093 | 5.342 | 567 | 6.940 | 14.327 | 10.317 | 64.900 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4712 - 4712" | |||||||||
| CAEN Financial Year |
4775
|
|||||||||
Comments - Doxicomdes S.r.l.